Can the amniotic membrane be used to treat peripheral nerve defects? A review of literature

Human amniotic membrane is currently being used in ophthalmology and dermatology applications. The objective of this review was to establish proof-of-concept for using amniotic membrane to treat peripheral nerve defects. We performed a search using: 1) PubMed with the keywords/MeSH terms: ``amnion'', ``amniotic membrane'', ``angiogenesis'', ``anti-microbial'', ``characteristic'', ``chorion'', ``epithelialization'', ``fibrosis'', ``gap'', ``growth factors'', ``use'', ``nerve''; 2) the American clinical trials registry with ``amniotic membrane''; 3) Lim Jeremy's book ``A primer on amniotic membrane regenerative healing''; 4) the search engine Google. Our findings pointed to the amniotic membrane being a biodegradable and bioactive scaffold that contains many growth factors important for efficient nerve regeneration. Multiple animal studies and the single human clinical trial performed up to now have highlighted its role in preventing recurrence of perineural adhesions, reducing fibrosis, accelerating nerve repair and improving nerve function. Thus, the amniotic membrane has ideal properties for treating peripheral nerve injuries. It could very likely prevent neuroma formation. The best format would be a freeze-dried one containing the amnion and chorion layers in order to preserve all its growth factors, and facilitate its handling and storage in the operating room. (C) 2019 SFCM. Published by Elsevier Masson SAS. All rights reserved.